Literature DB >> 1924515

The effects of 6-OHDA-induced dopamine depletions in the ventral or dorsal striatum on maternal and sexual behavior in the female rat.

S Hansen1, C Harthon, E Wallin, L Löfberg, K Svensson.   

Abstract

The effects of dopamine-depleting 6-OHDA infusions in the ventral or dorsal striatum on maternal and sexual behaviors were examined in female rats. Like sham-operated controls, lactating rats receiving 6-OHDA in the ventral striatum built good nests, nursed the infants and showed maternal aggression toward strange intruders. By contrast, the lesioned females performed poorly in tests for pup retrieval, as reflected in greatly protracted retrieval latencies. There was no effect of ventral striatal DA depletions on proceptive and receptive elements of female sexual behavior, which was studied after lactation following ovariectomy and exogenous administration of ovarian hormones, but these animals did show an attenuated hyperactivity response to a low dose of amphetamine. Females with dopamine lesions in the dorsal striatum did not differ from controls with respect to maternal and sexual behavior, but they did show an enhanced hyperactivity response to amphetamine treatment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1924515     DOI: 10.1016/0091-3057(91)90399-m

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  44 in total

Review 1.  Neural mechanisms of reproduction in females as a predisposing factor for drug addiction.

Authors:  Valerie L Hedges; Nancy A Staffend; Robert L Meisel
Journal:  Front Neuroendocrinol       Date:  2010-02-19       Impact factor: 8.606

2.  Pup suckling is more rewarding than cocaine: evidence from functional magnetic resonance imaging and three-dimensional computational analysis.

Authors:  Craig F Ferris; Praveen Kulkarni; John M Sullivan; Josie A Harder; Tara L Messenger; Marcelo Febo
Journal:  J Neurosci       Date:  2005-01-05       Impact factor: 6.167

3.  Motivational aspects of maternal anxiolysis in lactating rats.

Authors:  M Pereira; N Uriarte; D Agrati; M J Zuluaga; A Ferreira
Journal:  Psychopharmacology (Berl)       Date:  2005-03-19       Impact factor: 4.530

Review 4.  Functional mapping of the neural circuitry of rat maternal motivation: effects of site-specific transient neural inactivation.

Authors:  M Pereira; J I Morrell
Journal:  J Neuroendocrinol       Date:  2011-11       Impact factor: 3.627

5.  Specifying the neurobiological basis of human attachment: brain, hormones, and behavior in synchronous and intrusive mothers.

Authors:  Shir Atzil; Talma Hendler; Ruth Feldman
Journal:  Neuropsychopharmacology       Date:  2011-08-31       Impact factor: 7.853

6.  Effects of 5-hydroxytryptamine 2C receptor agonist MK212 and 2A receptor antagonist MDL100907 on maternal behavior in postpartum female rats.

Authors:  Weihai Chen; Qi Zhang; Wenxin Su; Haorong Zhang; Yu Yang; Jing Qiao; Nan Sui; Ming Li
Journal:  Pharmacol Biochem Behav       Date:  2013-12-07       Impact factor: 3.533

Review 7.  Maternally responsive neurons in the bed nucleus of the stria terminalis and medial preoptic area: Putative circuits for regulating anxiety and reward.

Authors:  Jenna A McHenry; David R Rubinow; Garret D Stuber
Journal:  Front Neuroendocrinol       Date:  2015-04-21       Impact factor: 8.606

8.  Exposure to pups influences the strength of maternal motivation in virgin female rats.

Authors:  Katharine M Seip; Joan I Morrell
Journal:  Physiol Behav       Date:  2008-09-09

9.  Behavioral, pharmacological and neuroanatomical analysis of serotonin 2C receptor agonism on maternal behavior in rats.

Authors:  Ruiyong Wu; Jun Gao; Shinnyi Chou; Collin Davis; Ming Li
Journal:  Psychoneuroendocrinology       Date:  2016-08-16       Impact factor: 4.905

10.  Effects of pair bonding on parental behavior and dopamine activity in the nucleus accumbens in male prairie voles.

Authors:  K Lei; Y Liu; A S Smith; J S Lonstein; Z Wang
Journal:  Eur J Neurosci       Date:  2017-09-18       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.